Page last updated: 2024-11-10

n,n'-4-xylylenebis(pyridinium)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID3036637
SCHEMBL ID2831425
MeSH IDM0134612

Synonyms (32)

Synonym
1,1'-(p-phenylenedimethylene)bis(pyridinium bromide)
pyridinium, 1,1'-(1,4-phenylenebis(methylene))bis-, dibromide
n,n'-4-xylylenebis(pyridinium)
pyridinium, 1,1'-(p-phenylenedimethylene)bis-, dibromide
pyridinium, 1,1'-(p-phenylenedimethylene)di-, dibromide
14208-10-7
p-xylene-bis(n-pyridinium bromide)
FT-0606023
p-xylylene-a,a'-bispyridinium dibromide
SCHEMBL2831425
1,1'-[1,4-phenylenebis(methylene)]-bispyridinium dibromide
AKOS025116680
mfcd00043749
1-({4-[(pyridin-1-ium-1-yl)methyl]phenyl}methyl)pyridin-1-ium dibromide
AS-72213
J-007595
p-xylylene bis(pyridinium) bromide
1,1'-(1,4-phenylenebis(methylene))dipyridinium bromide
1-[[4-(pyridin-1-ium-1-ylmethyl)phenyl]methyl]pyridin-1-ium;dibromide
1,1'-(1,4-phenylenebis(methylene))bis(pyridin-1-ium) bromi
CS-0188132
pyridinium,1,1'-[1,4-phenylenebis(methylene)]bis-,dibromide(9ci)
1,1'-[1,4-phenylenebis(methylene)]di(pyridin-1-ium) dibromide
DTXSID50931330
p-xylylene-alpha,alpha'-bispyridinium dibromide
1,1'-(p-xylylene)bis(1-pyridinium) dibromide
P2141
1,1'-(p-xylylene)bis(1-pyridinium bromide)
1,1'-[1,4-phenylenebis(methylene)]bis(1-pyridinium) dibromide
pyridinium, 1,1'-[1,4-phenylenebis(methylene)]bis-, dibromide (9ci)
D92191
1,1'-(1,4-phenylenebis(methylene))bis(pyridin-1-ium) bromide

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" At high phospholipid concentrations, the leakage of CF from PC LUVs deviates from a simple dose-response relationship, and it appears that some of the squalamine can no longer cause leakage."( The aminosterol antibiotic squalamine permeabilizes large unilamellar phospholipid vesicles.
Dollahon, NR; Fojtik, KG; Jones, SR; Selinsky, BS; Shinnar, AE; Zhou, Z, 1998
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AcetylcholinesteraseHomo sapiens (human)IC50 (µMol)1,540.00000.00000.933210.0000AID465559
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (14)

Processvia Protein(s)Taxonomy
acetylcholine catabolic process in synaptic cleftAcetylcholinesteraseHomo sapiens (human)
regulation of receptor recyclingAcetylcholinesteraseHomo sapiens (human)
osteoblast developmentAcetylcholinesteraseHomo sapiens (human)
acetylcholine catabolic processAcetylcholinesteraseHomo sapiens (human)
cell adhesionAcetylcholinesteraseHomo sapiens (human)
nervous system developmentAcetylcholinesteraseHomo sapiens (human)
synapse assemblyAcetylcholinesteraseHomo sapiens (human)
receptor internalizationAcetylcholinesteraseHomo sapiens (human)
negative regulation of synaptic transmission, cholinergicAcetylcholinesteraseHomo sapiens (human)
amyloid precursor protein metabolic processAcetylcholinesteraseHomo sapiens (human)
positive regulation of protein secretionAcetylcholinesteraseHomo sapiens (human)
retina development in camera-type eyeAcetylcholinesteraseHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholinesteraseHomo sapiens (human)
positive regulation of cold-induced thermogenesisAcetylcholinesteraseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
amyloid-beta bindingAcetylcholinesteraseHomo sapiens (human)
acetylcholinesterase activityAcetylcholinesteraseHomo sapiens (human)
cholinesterase activityAcetylcholinesteraseHomo sapiens (human)
protein bindingAcetylcholinesteraseHomo sapiens (human)
collagen bindingAcetylcholinesteraseHomo sapiens (human)
hydrolase activityAcetylcholinesteraseHomo sapiens (human)
serine hydrolase activityAcetylcholinesteraseHomo sapiens (human)
acetylcholine bindingAcetylcholinesteraseHomo sapiens (human)
protein homodimerization activityAcetylcholinesteraseHomo sapiens (human)
laminin bindingAcetylcholinesteraseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (13)

Processvia Protein(s)Taxonomy
extracellular regionAcetylcholinesteraseHomo sapiens (human)
basement membraneAcetylcholinesteraseHomo sapiens (human)
extracellular spaceAcetylcholinesteraseHomo sapiens (human)
nucleusAcetylcholinesteraseHomo sapiens (human)
Golgi apparatusAcetylcholinesteraseHomo sapiens (human)
plasma membraneAcetylcholinesteraseHomo sapiens (human)
cell surfaceAcetylcholinesteraseHomo sapiens (human)
membraneAcetylcholinesteraseHomo sapiens (human)
neuromuscular junctionAcetylcholinesteraseHomo sapiens (human)
synaptic cleftAcetylcholinesteraseHomo sapiens (human)
synapseAcetylcholinesteraseHomo sapiens (human)
perinuclear region of cytoplasmAcetylcholinesteraseHomo sapiens (human)
side of membraneAcetylcholinesteraseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID465559Inhibition of human erythrocyte AChE after 5 mins by Ellman's method2010Bioorganic & medicinal chemistry letters, Mar-01, Volume: 20, Issue:5
Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.
AID465560Inhibition of human plasma BChE after 5 mins by Ellman's method2010Bioorganic & medicinal chemistry letters, Mar-01, Volume: 20, Issue:5
Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (14.81)18.7374
1990's11 (40.74)18.2507
2000's6 (22.22)29.6817
2010's6 (22.22)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.38 (24.57)
Research Supply Index3.37 (2.92)
Research Growth Index4.74 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other28 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]